Showing 1821-1830 of 2050 results for "".
- First COVID-19 Vaccine Doses To Go To Health Workers, Say CDC Advisershttps://modernod.com/news/first-covid-19-vaccine-doses-to-go-to-health-workers-say-cdc-advisers/2478502/Health care workers will almost certainly get the first doses of COVID-19 vaccine in the U.S. when one is approved, according to Dr. José Romero, head of the committee that develops evidence-based immunization guidelines for the Centers for Disease Control and Prevention, as
- Aerie Pharmaceuticals Initiates Phase 2b Clinical Trial of AR-15512 for the Treatment of Dry Eye Diseasehttps://modernod.com/news/aerie-pharmaceuticals-initiates-phase-2b-clinical-trial-of-ar-15512-trpm8-agonist-ophthalmic-solution-for-the-treatment-of-patients-with-dry-eye-disease/2478473/Aerie Pharmaceuticals announced the commencement of COMET-1, a phase 2b clinical trial of AR-15512 (TRPM8 agonist) ophthalmic solution for the treatment of patients with dry eye disease. The COMET-1 trial is a randomized, double-masked, vehicle-controlled trial evaluating the efficacy and
- CDC Warns of “Distressing Trend” With Increased COVID-19 Cases Across Nearly 75% of the Countryhttps://modernod.com/news/cdc-warns-of-distressing-trend-with-increased-covid-19-cases-across-nearly-75-of-the-country/2478447/The spread of COVID-19 cases is on the rise in nearly 75% of the country as cases start to swell with the weathering turning cooler, according to the Centers for Disease Control and Prevention, FierceHealthcare
- Appeals Court Skeptical of AHA in Lawsuit Over HHS Price Transparency Rulehttps://modernod.com/news/appeals-court-skeptical-of-aha-in-lawsuit-over-hhs-price-transparency-rule/2478425/A trio of appellate judges was very skeptical of the hospital industry’s arguments that a controversial price transparency rule set to go into effect in January should be struck down, according to a FierceHealthcare
- BVI Acquires Benz Research & Development, Strengthening IOL Design, Production and Sales Capabilitieshttps://modernod.com/news/bvi-acquires-benz-research-development-strengthening-iol-design-production-and-sales-capabilities/2478419/BVI announced its recent completion of the acquisition of Benz Research & Development and its customized contact lens subsidiary, SpecialEyes, both based in Sarasota, Florida. Terms of the deal were not disclosed. The Benz portfolio of performanc
- CooperVision Presents 6-Year Data from MiSight 1 Day Studyhttps://modernod.com/news/coopervision-presents-6-year-data-from-misight-1-day-study/2478397/CooperVision is reporting the latest findings from its landmark MiSight 1 day clinical study, providing new insights about myopia management and the efficacy of the specially designed contact lens. Among many powerful outcomes are that nearly one in four children’s eyes originally fit with MiSigh
- Bausch + Lomb Announces New Scientific and Clinical Analyses to be Presented at American Academy of Optometry Annual Meetinghttps://modernod.com/news/bausch-lomb-announces-new-scientific-and-clinical-analyses-to-be-presented-at-american-academy-of-optometry-annual-meeting/2478386/Bausch + Lomb announced that three poster presentations will feature the company’s new silicone hydrogel (SiHy) daily disposable contact lens, Bausch + Lomb Infuse, during the virtual American Academy of Optometry (AAO) annual meeting (Oct. 7-22, 2020). “Over the past two decades, we have
- Equinox Ophthalmic Appoints Stuart Raetzman as Executive Chairhttps://modernod.com/news/equinox-ophthalmic-appoints-stuart-raetzman-as-executive-chair/2478384/Equinox Ophthalmic announced the appointment of Stuart Raetzman as Executive Chairman. Company founder, John Berdahl, MD, will continue to serve on the Board of Directors and as Chief Medical Officer. Equinox Ophthalmic is a company focused on addressing the unmet need in glau
- Alcon to Showcase Innovations at #Academy20 that Support Recovery and Growth for Eye Care Practiceshttps://modernod.com/news/alcon-to-showcase-innovations-at-academy20-that-support-recovery-and-growth-for-eye-care-practices/2478379/Alcon will highlight leading innovations and clinical research at the 2020 American Academy of Optometry (#Academy20) meeting taking place virtually from October 7-22, 2020. The company’s virtual program will feature updates on its most important innovations, including Precision1 one-day contact
- Tarsus Releases Data from Io and Europa Trials for TP-03 to Treat Demodex Blepharitis and Begins Phase 2b/3 Saturn-1 Trialhttps://modernod.com/news/tarsus-releases-data-from-io-and-europa-trials-for-tp-03-to-treat-demodex-blepharitis-and-begins-phase-2b-3-saturn-1-trial/2478374/Tarsus Pharmaceuticals announced data from its phase 2 trials, Io (a Phase 2a, single-arm open-label trial) and Europa (a Phase 2b, randomized vehicle-controlled trial), evaluating the safety and efficacy of TP-03, a novel ophthalmic therapeutic being developed for t